Immunohistochemical analysis demonstrated a significant converse correlation of FBXO16 and β‐catenin expression with increased levels of β‐catenin and concomitant attenuation of FBXO16 in higher grades of breast cancer patient samples (Figure 1E). The gene discussed is FBXO16; the disease is breast cancer.